asked the Secretary of State for Social Services if he will make a statement on the continuing availability of the pregnancy anti-emetic drug Debendox on EC10 prescription forms issued by general practitioners, in the light of current reports from the United States of America that the drug has possible tetrogenic effects.
I refer the hon. Member to my reply to the right hon. Member for Stoke-on-Trent, South (Mr. Ashley) on 24 January—[Vol. 977, c. 336–7]—and to my hon. Friend's reply to his further question on 4 February.